These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7901879)

  • 1. New developments in the treatment of asthma and chronic obstructive pulmonary disease.
    Barnes NC
    Respir Med; 1993 Aug; 87 Suppl B():53-6. PubMed ID: 7901879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy].
    Hahn HL
    Verh Dtsch Ges Inn Med; 1988; 94():364-75. PubMed ID: 2905102
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment in asthma and COPD.
    Wempe JB; Renkema TE; Koëter GH; Postma DS
    Eur Respir J; 1990 Oct; 3(9):1089-91. PubMed ID: 1981192
    [No Abstract]   [Full Text] [Related]  

  • 4. [New directions in pharmacotherapy for bronchial asthma].
    Klin MJ; Brewczyński PZ
    Pol Tyg Lek; 1993 Feb 15-22; 48(7-8):181-7. PubMed ID: 8105454
    [No Abstract]   [Full Text] [Related]  

  • 5. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
    van Schayck CP; Postma DS; Lammers JW
    Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies.
    Skorodin MS
    Arch Intern Med; 1993 Apr; 153(7):814-28. PubMed ID: 8096690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do "real life" studies tell us about asthma controllers?
    Williams PV
    J Allergy Clin Immunol Pract; 2014; 2(5):614-5. PubMed ID: 25213057
    [No Abstract]   [Full Text] [Related]  

  • 8. Some aspects of the management of bronchial asthma and chronic obstructive lung disease.
    Rowe WS
    Med J Aust; 1975 May; 1(20):623-5. PubMed ID: 238095
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of leukotriene receptor antagonists on prognosis of patients with bronchial asthma].
    Nagata M
    Arerugi; 2007 Nov; 56(11):1408. PubMed ID: 18059156
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asthma: current therapeutic approach].
    Bononi F; Mazzone M; Portale G; Forte P; Falcone C; Silveri NG
    Recenti Prog Med; 2005 Oct; 96(10):494-8. PubMed ID: 16491774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal pharmacologic treatment of the critically ill patient with obstructive airways disease.
    Siefkin AD
    Am J Med; 1996 Jan; 100(1A):54S-61S. PubMed ID: 8610719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP; Lee DK; Menzies D; Lipworth BJ
    Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
    [No Abstract]   [Full Text] [Related]  

  • 16. Setting the gold standard: clinical and economic decision making in asthma management.
    O'Connor RD
    Manag Care; 2003 Jan; 12(1 Suppl):11-7. PubMed ID: 18567330
    [No Abstract]   [Full Text] [Related]  

  • 17. The expanding role of leukotriene receptor antagonists in chronic asthma.
    Currie GP; McLaughlin K
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):731-41, quiz 741-2, 793. PubMed ID: 17201231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we overtreating recurrent wheezing in infancy?
    Rosario NA; Chong Neto HJ
    Allergol Immunopathol (Madr); 2009; 37(5):276-8. PubMed ID: 19783346
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy--first-line maintenance therapy.
    CMAJ; 2005 Sep; 173(6 Suppl):S28-32. PubMed ID: 16157732
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.